跳至主要内容
临床试验/EUCTR2020-004826-47-DK
EUCTR2020-004826-47-DK进行中(未招募)1 期

Intraoperative methadone for postoperative pain management in spinal fusion surgery: a prospective, double-blind, randomised controlled trial - METASPINE

one Nikolajsen0 个研究点目标入组 150 人开始时间: 2020年10月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All patients (=18 years) scheduled for elective spine surgery are screened for inclusion.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • Allergy to study drugs
  • American Society of Anaesthesiologists (ASA) physical status IV or V
  • Prolonged QTc-interval assessed by electrocardiogram (Male: >450 milliseconds, Female: >460 milliseconds)
  • Inability to provide informed consent
  • Severe respiratory insufficiency (Oxygen treatment at home)
  • Heart failure
  • Acute alcohol intoxication/delirium tremens
  • Increased intracranial pressure
  • Acute liver disease
  • Acute abdominal pain
  • Liver insufficiency
  • Kidney insufficiency (eGFR<30)
  • Pregnancy or breastfeeding
  • Existing treatment with medications prolonging the QT-interval (see appendix for details)
  • Existing treatment with opioids (at least the last 7 days) exceeding 60 mg morphine equivalents daily
  • Planned postoperative treatment with epidural analgesics and/or ketamine infusion
  • Treatment with rifampicin
  • Spinal surgery due to malignant disease

研究者

发起方
one Nikolajsen

相似试验